233 related articles for article (PubMed ID: 15801856)
1. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
[TBL] [Abstract][Full Text] [Related]
2. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
3. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
[TBL] [Abstract][Full Text] [Related]
4. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
5. O-N intramolecular acyl migration strategy in water-soluble prodrugs of taxoids.
Skwarczynski M; Sohma Y; Kimura M; Hayashi Y; Kimura T; Kiso Y
Bioorg Med Chem Lett; 2003 Dec; 13(24):4441-4. PubMed ID: 14643342
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
Mäntylä A; Rautio J; Nevalainen T; Keski-Rahkonen P; Vepsälainen J; Järvinen T
Eur J Pharm Sci; 2004 Oct; 23(2):151-8. PubMed ID: 15451003
[TBL] [Abstract][Full Text] [Related]
7. New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration.
Hamada Y; Ohtake J; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2002 Dec; 10(12):4155-67. PubMed ID: 12413869
[TBL] [Abstract][Full Text] [Related]
8. Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs.
Noguchi M; Skwarczynski M; Prakash H; Hirota S; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2008 May; 16(10):5389-97. PubMed ID: 18440235
[TBL] [Abstract][Full Text] [Related]
9. Application of the O-N intramolecular acyl migration reaction in medicinal chemistry.
Skwarczynski M; Kiso Y
Curr Med Chem; 2007; 14(26):2813-23. PubMed ID: 18045127
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
11. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
12. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
13. Bioreversible quaternary N-acyloxymethyl derivatives of the tertiary amines bupivacaine and lidocaine--synthesis, aqueous solubility and stability in buffer, human plasma and simulated intestinal fluid.
Nielsen AB; Buur A; Larsen C
Eur J Pharm Sci; 2005 Apr; 24(5):433-40. PubMed ID: 15784333
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Hamel AR; Hubler F; Mutter M
J Pept Res; 2005 Mar; 65(3):364-74. PubMed ID: 15787967
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).
Leu YL; Roffler SR; Chern JW
J Med Chem; 1999 Sep; 42(18):3623-8. PubMed ID: 10479293
[TBL] [Abstract][Full Text] [Related]
16. Effect of the acyl groups on O-->N acyl migration in the water-soluble prodrugs of HIV-1 protease inhibitor.
Hamada Y; Matsumoto H; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2003 Aug; 13(16):2727-30. PubMed ID: 12873502
[TBL] [Abstract][Full Text] [Related]
17. Novel prodrugs with a spontaneous cleavable guanidine moiety.
Hamada Y
Bioorg Med Chem Lett; 2016 Apr; 26(7):1685-9. PubMed ID: 26923694
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs.
Montenegro L; Carbone C; Maniscalco C; Lambusta D; Nicolosi G; Ventura CA; Puglisi G
Int J Pharm; 2007 May; 336(2):257-62. PubMed ID: 17257788
[TBL] [Abstract][Full Text] [Related]
19. Regioselectivity of taxoid-O-acetyltransferases: heterologous expression and characterization of a new taxadien-5alpha-ol-O-acetyltransferase.
Chau M; Walker K; Long R; Croteau R
Arch Biochem Biophys; 2004 Oct; 430(2):237-46. PubMed ID: 15369823
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity.
Chen P; Luo Y; Hai L; Qian S; Wu Y
Eur J Med Chem; 2010 Jul; 45(7):3005-10. PubMed ID: 20392547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
